Recall, the IBB was +8% at the end of January.
About Friday's selloff. This is what it looks like mapped against the entire week's trading. We've seen dips like this before in the biotech bull market and they were all bought aggressively. Monday's trading will be interesting to watch.
Here's how the big-cap biotechs are performing year to date:
The best-performing biotech and drug stocks after two months of 2014:
1. Intercept Pharma (ICPT - Get Report) + 501%
2. Tekmira Pharma (TKMR) +166%
3. Rexahn Pharma (RNN)+165%
4. Imprimis Pharma (IMMY) +157%
5. Retrophin Pharma (RTRX - Get Report) +152%
10/14/15 - 11:47 AM EDT
05/19/15 - 04:42 PM EDT
05/19/15 - 12:48 PM EDT
05/18/15 - 08:06 AM EDT
05/05/15 - 02:43 PM EDT
05/05/16 - 17:32 PM EDT
05/05/16 - 17:17 PM EDT
05/05/16 - 13:45 PM EDT
05/05/16 - 13:15 PM EDT
05/04/16 - 18:23 PM EDT
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Chris Versace, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.
Master swing trader Alan Farley uses his sophisticated software screens to review thousands of stocks each day for you, to find just the handful that meet his demanding criteria.